Het waren twee fantastische dagen bij #RICS 2023 afgelopen week!
Een programma vol met de nieuwste inzichten op het gebied van beademing. Leuk dat PulmoTech BV een bijdrage mocht geven in de vorm van een pitch, en dat we hiermee als startup een podium hebben gekregen. We kijken uit naar de opvolging van de vele gevoerde gesprekken.
Bedankt voor de wederom geweldige organisatie Dolf Weller en team. Tot volgend jaar!
🎉🔬 We are excited to announce that PulmoTech BV has earned its ISO 13485 certification! 🎉🔬
This international standard for Quality Management Systems in the medical devices industry underscores our dedication to providing high-quality products and services.
Achieving ISO 13485 is a testament to the hard work of our team and our commitment to patient safety.
Thank you to our partners and stakeholders for your trust and support. We look forward to further contributing to better patient outcomes with our intelligent Esophageal Pressure System. Next up: CE certification under MDR.
🎉 Exciting News! 🚀 We’ve achieved a monumental milestone: Our intelligent Esophageal Pressure System has been awarded the CE mark under the rigorous Medical Device Regulation (MDR). 🌟
🛠️ It’s been a thrilling journey of five years filled with relentless dedication and persistence. From a mere concept by a patient’s bedside to a groundbreaking reality, we’re now proudly stepping into the European market.
👏 A huge shoutout to our compact yet mighty team: Niels van Rheenen, Rik Schaart, and Rick Boerma, you rock! And a heartfelt thanks to Annemijn Jonkman and Leo Heunks for their invaluable clinical support right from the start. Couldn’t have done it without you! 🙏
🔍 We’re now keenly looking for new strategic and investment partners to scale our technology and touch the lives of as many critically ill patients as possible. Interested? 📩 Send us a message!
It is with great pleasure we can announce Carduso Capital invests in PulmoTech BV. More information is available by the Nothern Times and on the website of Carduso Capital.
In the next phase we will work hard to bring our innovative esophageal catheter to the market. We aim to give intensivists the right tools to support patients who need it the most, the (mechanically) ventilated critically ill. Very proud of our team for making this possible!
Also a big thank you for the support we’ve got to achieve this important milestone; VentureLab International North, Flinc, Netherlands Enterprise Agency (RVO.nl), Medical Device Project B.V., Matrix Requirements, Factory CRO for Medical Devices and IVDs, Marion van der Heden, Semme Moolenaar.
Rutger had an interesting interview with the ‘Investerings- en Ontwikkelingsmaatschappij voor Noord Nederland’ (NOM), regarding the start of PulmoTech. The interview is available here (in Dutch).
